Open AccessResponse to zoledronic acid in patients with active Paget's disease of bone: A retrospective study
Author(s) -
Harsh Durgia,
Jayaprakash Sahoo,
Sadishkumar Kamalanathan,
Rajan Palui,
Ramesh Kumar,
Dhanapathi Halanaik,
Ramesh Ananthakrishnan,
G. R. Maruthi Sankar,
Kalyani Sridharan,
Henith Raj
Publication year - 2019
Publication title -
indian journal of endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.456
H-Index - 28
eISSN - 2230-9500
pISSN - 2230-8210
DOI - 10.4103/ijem.ijem_327_18
Subject(s) - medicine , interquartile range , zoledronic acid , retrospective cohort study , paget's disease of bone , alkaline phosphatase , elevated alkaline phosphatase , bone pain , gastroenterology , disease , biochemistry , chemistry , enzyme
Traditionally, bisphosphonates are used to treat active Paget's disease of bone (PDB). Intravenous zoledronic acid (ZA) is the most effective treatment option leading to sustained remission.